ArticleMolecular cancer therapeutics2023

Targeting Aggressive B-cell Lymphomas through Pharmacological Activation of the Mitochondrial Protease OMA1.

Adrian Schwarzer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.